查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1349403

單核細胞活化測試市場（產品類型：MAT 試劑盒和試劑；來源：基於 PBMC 和基於細胞系）- 全球產業分析、規模、佔有率、成長、趨勢和預測，2023-2031 年

Monocyte Activation Test Market (Product Type: MAT Kits and Reagents; and Source: PBMC Based and Cell Line Based) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
出版日期: | 出版商: Transparency Market Research | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

單核細胞活化測試市場 - 報告範圍

TMR 關於全球單核細胞活化測試市場的報告研究了過去以及當前的成長趨勢和機會，以獲得 2023 年至 2031 年預測期內市場指標的寶貴見解。該報告提供了全球單核細胞活化測試的收入2017-2031年期間的市場，考慮2023年為基準年，2031年為預測年。報告中也提供了2023年至2031年全球單核細胞活化測試市場的年複合成長率（CAGR%）。

該報告是經過廣泛研究後編寫的。初級研究涉及大部分研究工作，其中分析師對關鍵意見領袖、行業領導者和輿論製造者進行了採訪。二次研究涉及參考主要參與者的產品文獻、年度報告、新聞稿和相關文件，以了解單核細胞活化測試市場。

市場概況
2023年市場價值 6070萬美元
2031 年市場價值 3.053 億美元
年複合成長率 0.198%

該報告深入探討了全球單核細胞活化測試市場的競爭格局。全球單核細胞活化測試市場的主要參與者已被確定，並且每一位參與者都已根據各種屬性進行了分析。公司概況、財務狀況、最新發展和 SWOT 是本報告中介紹的全球單核細胞活化測試市場參與者的屬性。

目錄

第一章：前言

第 2 章：假設與研究方法

第 3 章：執行摘要：全球市場

第 4 章：市場概述

  • 介紹
  • 概述
  • 市場動態
  • 2017-2031年全球市場分析與預測

第 5 章：關鍵見解

  • 熱原測試的進展
  • 醫療保健行業概覽
  • COVID-19 大流行對產業的影響（價值鍊和短期/中期/長期影響）
  • 技術進步

第 6 章：全球市場分析與預測：依產品類型

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依產品類型，2017-2031
    • 墊套件
    • 試劑
  • 市場吸引力分析：按產品類型

第 7 章：全球市場分析與預測：按來源

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依來源分類，2017-2031
    • 基於PBMC
    • 基於細胞系
  • 市場吸引力分析：按來源

第 8 章：全球市場分析與預測：按應用分類

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：依應用分類，2017-2031
    • 藥物開發
    • 疫苗開發
    • 醫療器材測試
    • 其他（研究等）
  • 市場吸引力分析：按應用

第 9 章：全球市場分析與預測：按最終用戶

  • 簡介與定義
  • 主要發現/進展
  • 市場價值預測：按最終用戶，2017-2031
    • 醫藥行業
    • 生技產業
    • 醫療器材業
    • 其他（CRO、學術研究機構等）
  • 市場吸引力分析：按最終用戶

第 10 章：全球市場分析與預測：按地區

  • 主要發現
  • 市場價值預測：按地區，2017-2031
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 按國家/地區分類的市場吸引力

第 11 章：北美市場分析與預測

第 12 章：歐洲市場分析與預測

第 13 章：亞太市場分析與預測

第 14 章：拉丁美洲市場分析與預測

第 15 章：中東和非洲市場分析與預測

第16章：競爭格局

  • 市場參與者 - 競爭矩陣（依公司層級和規模）
  • 市佔率分析：依公司分類（2021 年）
  • 公司簡介
    • Merck KGaA
    • Thermo Fisher Scientific
    • Charles River Laboratories International, Inc.
    • Sanquin
    • Microcoat Biotechnologie GmbH
    • SOLVIAS AG
    • Lonza Group
    • Becton, Dickinson and Company
Product Code: TMRGL36041

Monocyte Activation Test Market - Scope of Report

TMR's report on the global monocyte activation test market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global monocyte activation test market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global monocyte activation test market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the monocyte activation test market.

Market Snapshot
Market Value in 2023US$ 60.7 Mn
Market Value in 2031US$ 305.3 Mn
CAGR19.8%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global monocyte activation test market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global monocyte activation test market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global monocyte activation test market.

The report delves into the competitive landscape of the global monocyte activation test market. Key players operating in the global monocyte activation test market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global monocyte activation test market profiled in this report.

Key Questions Answered in Global Monocyte Activation Test Market Report:

  • What is the sales/revenue generated by monocyte activation test across all regions during the forecast period?
  • What are the opportunities in the global monocyte activation test market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2031?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?

Monocyte Activation Test Market - Research Objectives and Research Approach

The comprehensive report on the global monocyte activation test market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global monocyte activation test market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global monocyte activation test market.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Monocyte Activation Test Market

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Product Definition
    • 4.1.2. Industry Evolution / Development
  • 4.2. Overview
  • 4.3. Market Dynamics
    • 4.3.1. Drivers
    • 4.3.2. Restraints
    • 4.3.3. Opportunities
  • 4.4. Global Monocyte Activation Test Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Advancement in Pyrogen Tests
  • 5.2. Healthcare Industry Overview
  • 5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long Term Impact)
  • 5.4. Technological Advancements

6. Global Monocyte Activation Test Market Analysis and Forecast, by Product Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Product Type, 2017-2031
    • 6.3.1. MAT Kits
    • 6.3.2. Reagents
  • 6.4. Market Attractiveness Analysis, by Product Type

7. Global Monocyte Activation Test Market Analysis and Forecast, by Source

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Source, 2017-2031
    • 7.3.1. PBMC Based
    • 7.3.2. Cell Line Based
  • 7.4. Market Attractiveness Analysis, by Source

8. Global Monocyte Activation Test Market Analysis and Forecasts, by Application

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by Application, 2017-2031
    • 8.3.1. Drug Development
    • 8.3.2. Vaccine Development
    • 8.3.3. Medical Device Testing
    • 8.3.4. Others (Research, etc.)
  • 8.4. Market Attractiveness Analysis, by Application

9. Global Monocyte Activation Test Market Analysis and Forecast, by End-user

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by End-user, 2017-2031
    • 9.3.1. Pharmaceutical Industry
    • 9.3.2. Biotechnology Industry
    • 9.3.3. Medical Device Industry
    • 9.3.4. Others (CROs, Academic & Research Institute, etc.)
  • 9.4. Market Attractiveness Analysis, by End-user

10. Global Monocyte Activation Test Market Analysis and Forecast, by Region

  • 10.1. Key Findings
  • 10.2. Market Value Forecast, by Region, 2017-2031
    • 10.2.1. North America
    • 10.2.2. Europe
    • 10.2.3. Asia Pacific
    • 10.2.4. Latin America
    • 10.2.5. Middle East & Africa
  • 10.3. Market Attractiveness By Country/Region

11. North America Monocyte Activation Test Market Analysis and Forecast

  • 11.1. Introduction
    • 11.1.1. Key Findings
  • 11.2. Market Value Forecast, by Product Type, 2017-2031
    • 11.2.1. MAT Kits
    • 11.2.2. Reagents
  • 11.3. Market Value Forecast, by Source, 2017-2031
    • 11.3.1. PBMC Based
    • 11.3.2. Cell Line Based
  • 11.4. Market Value Forecast, by Application, 2017-2031
    • 11.4.1. Drug Development
    • 11.4.2. Vaccine Development
    • 11.4.3. Medical Device Testing
    • 11.4.4. Others (Research, etc.)
  • 11.5. Market Value Forecast, by End-user, 2017-2031
    • 11.5.1. Pharmaceutical Industry
    • 11.5.2. Biotechnology Industry
    • 11.5.3. Medical Device Industry
    • 11.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 11.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 11.6.1. U.S.
    • 11.6.2. Canada
  • 11.7. Market Attractiveness Analysis
    • 11.7.1. By Product Type
    • 11.7.2. By Source
    • 11.7.3. By Application
    • 11.7.4. By End-user
    • 11.7.5. By Country/Sub-region

12. Europe Monocyte Activation Test Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Product Type, 2017-2031
    • 12.2.1. MAT Kits
    • 12.2.2. Reagents
  • 12.3. Market Value Forecast, by Source, 2017-2031
    • 12.3.1. PBMC Based
    • 12.3.2. Cell Line Based
  • 12.4. Market Value Forecast, by Application, 2017-2031
    • 12.4.1. Drug Development
    • 12.4.2. Vaccine Development
    • 12.4.3. Medical Device Testing
    • 12.4.4. Others (Research, etc.)
  • 12.5. Market Value Forecast, by End-user, 2017-2031
    • 12.5.1. Pharmaceutical Industry
    • 12.5.2. Biotechnology Industry
    • 12.5.3. Medical Device Industry
    • 12.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 12.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 12.6.1. Germany
    • 12.6.2. U.K.
    • 12.6.3. France
    • 12.6.4. Italy
    • 12.6.5. Spain
    • 12.6.6. Rest of Europe
  • 12.7. Market Attractiveness Analysis
    • 12.7.1. By Product Type
    • 12.7.2. By Source
    • 12.7.3. By Application
    • 12.7.4. By End-user
    • 12.7.5. By Country/Sub-region

13. Asia Pacific Monocyte Activation Test Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Product Type, 2017-2031
    • 13.2.1. MAT Kits
    • 13.2.2. Reagents
  • 13.3. Market Value Forecast, by Source, 2017-2031
    • 13.3.1. PBMC Based
    • 13.3.2. Cell Line Based
  • 13.4. Market Value Forecast, by Application, 2017-2031
    • 13.4.1. Drug Development
    • 13.4.2. Vaccine Development
    • 13.4.3. Medical Device Testing
    • 13.4.4. Others (Research, etc.)
  • 13.5. Market Value Forecast, by End-user, 2017-2031
    • 13.5.1. Pharmaceutical Industry
    • 13.5.2. Biotechnology Industry
    • 13.5.3. Medical Device Industry
    • 13.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 13.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 13.6.1. China
    • 13.6.2. Japan
    • 13.6.3. India
    • 13.6.4. Australia & New Zealand
    • 13.6.5. Rest of Asia Pacific
  • 13.7. Market Attractiveness Analysis
    • 13.7.1. By Product Type
    • 13.7.2. By Source
    • 13.7.3. By Application
    • 13.7.4. By End-user
    • 13.7.5. By Country/Sub-region

14. Latin America Monocyte Activation Test Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Product Type, 2017-2031
    • 14.2.1. MAT Kits
    • 14.2.2. Reagents
  • 14.3. Market Value Forecast, by Source, 2017-2031
    • 14.3.1. PBMC Based
    • 14.3.2. Cell Line Based
  • 14.4. Market Value Forecast, by Application, 2017-2031
    • 14.4.1. Drug Development
    • 14.4.2. Vaccine Development
    • 14.4.3. Medical Device Testing
    • 14.4.4. Others (Research, etc.)
  • 14.5. Market Value Forecast, by End-user, 2017-2031
    • 14.5.1. Pharmaceutical Industry
    • 14.5.2. Biotechnology Industry
    • 14.5.3. Medical Device Industry
    • 14.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 14.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.6.1. Brazil
    • 14.6.2. Mexico
    • 14.6.3. Rest of Latin America
  • 14.7. Market Attractiveness Analysis
    • 14.7.1. By Product Type
    • 14.7.2. By Source
    • 14.7.3. By Application
    • 14.7.4. By End-user
    • 14.7.5. By Country/Sub-region

15. Middle East & Africa Monocyte Activation Test Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Product Type, 2017-2031
    • 15.2.1. MAT Kits
    • 15.2.2. Reagents
  • 15.3. Market Value Forecast, by Source, 2017-2031
    • 15.3.1. PBMC Based
    • 15.3.2. Cell Line Based
  • 15.4. Market Value Forecast, by Application, 2017-2031
    • 15.4.1. Drug Development
    • 15.4.2. Vaccine Development
    • 15.4.3. Medical Device Testing
    • 15.4.4. Others (Research, etc.)
  • 15.5. Market Value Forecast, by End-user, 2017-2031
    • 15.5.1. Pharmaceutical Industry
    • 15.5.2. Biotechnology Industry
    • 15.5.3. Medical Device Industry
    • 15.5.4. Others (CROs, Academic & Research Institute, etc.)
  • 15.6. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.6.1. GCC Countries
    • 15.6.2. South Africa
    • 15.6.3. Rest of Middle East & Africa
  • 15.7. Market Attractiveness Analysis
    • 15.7.1. By Product Type
    • 15.7.2. By Source
    • 15.7.3. By Application
    • 15.7.4. By End-user
    • 15.7.5. By Country/Sub-region

16. Competition Landscape

  • 16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
  • 16.2. Market Share Analysis, by Company (2021)
  • 16.3. Company Profiles
    • 16.3.1. Merck KGaA
      • 16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.1.2. Product Portfolio
      • 16.3.1.3. Financial Overview
      • 16.3.1.4. SWOT Analysis
      • 16.3.1.5. Strategic Overview
    • 16.3.2. Thermo Fisher Scientific
      • 16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.2.2. Product Portfolio
      • 16.3.2.3. Financial Overview
      • 16.3.2.4. SWOT Analysis
      • 16.3.2.5. Strategic Overview
    • 16.3.3. Charles River Laboratories International, Inc.
      • 16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.3.2. Product Portfolio
      • 16.3.3.3. Financial Overview
      • 16.3.3.4. SWOT Analysis
      • 16.3.3.5. Strategic Overview
    • 16.3.4. Sanquin
      • 16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.4.2. Product Portfolio
      • 16.3.4.3. Financial Overview
      • 16.3.4.4. SWOT Analysis
      • 16.3.4.5. Strategic Overview
    • 16.3.5. Microcoat Biotechnologie GmbH
      • 16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.5.2. Product Portfolio
      • 16.3.5.3. Financial Overview
      • 16.3.5.4. SWOT Analysis
      • 16.3.5.5. Strategic Overview
    • 16.3.6. SOLVIAS AG
      • 16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.6.2. Product Portfolio
      • 16.3.6.3. Financial Overview
      • 16.3.6.4. SWOT Analysis
      • 16.3.6.5. Strategic Overview
    • 16.3.7. Lonza Group
      • 16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.7.2. Product Portfolio
      • 16.3.7.3. Financial Overview
      • 16.3.7.4. SWOT Analysis
      • 16.3.7.5. Strategic Overview
    • 16.3.8. Becton, Dickinson and Company
      • 16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 16.3.8.2. Product Portfolio
      • 16.3.8.3. Financial Overview
      • 16.3.8.4. SWOT Analysis
      • 16.3.8.5. Strategic Overview

List of Tables

  • Table 01: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 02: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 03: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 04: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 05: Global Monocyte Activation Test Market Size (US$ Mn) Forecast, by Region, 2017-2031
  • Table 06: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 07: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 08: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 09: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 10: North America Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 11: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 12: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 13: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 14: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 15: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 16: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 17: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 18: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 19: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 20: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 21: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 22: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 23: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 24: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 25: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031
  • Table 26: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 27: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Product Type, 2017-2031
  • Table 28: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Source, 2017-2031
  • Table 29: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by Application, 2017-2031
  • Table 30: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast, by End-user, 2017-2031

List of Figures

  • Figure 01: Global Monocyte Activation Test Market Size (US$ Mn) and Distribution, by Region, 2022 and 2031
  • Figure 02: Global Monocyte Activation Test Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 03: Global Monocyte Activation Test Market Value Share, by Product Type (2022)
  • Figure 04: Global Monocyte Activation Test Market Value Share, by Source (2022)
  • Figure 05: Global Monocyte Activation Test Market Value Share, by Application (2022)
  • Figure 06: Global Monocyte Activation Test Market Value Share, by End-user (2022)
  • Figure 07: Global Monocyte Activation Test Market Value Share, by Product Type, 2022 and 2031
  • Figure 08: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by MAT Kits, 2017-2031
  • Figure 09: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Reagents, 2017-2031
  • Figure 10: Global Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 11: Global Monocyte Activation Test Market Value Share, by Source, 2022 and 2031
  • Figure 12: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by PBMC Based, 2017-2031
  • Figure 13: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Cell Line Based, 2017-2031
  • Figure 14: Global Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 15: Global Monocyte Activation Test Market Value Share, by Application, 2022 and 2031
  • Figure 16: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Drug Development, 2017-2031
  • Figure 17: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Vaccine Development, 2017-2031
  • Figure 18: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Medical Device Testing, 2017-2031
  • Figure 19: Global Monocyte Activation Test Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others (Research, etc.), 2017-2031
  • Figure 20: Global Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 21: Global Monocyte Activation Test Market Value Share, by End-user, 2022 and 2031
  • Figure 22: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pharmaceutical Industry, 2017-2031
  • Figure 23: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Biotechnology Industry, 2017-2031
  • Figure 24: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Medical Device Industry, 2017-2031
  • Figure 25: Global Monocyte Activation Test Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2017-2031
  • Figure 26: Global Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 27: Global Monocyte Activation Test Market Value Share, by Region, 2022 and 2031
  • Figure 28: Global Monocyte Activation Test Market Attractiveness, by Region, 2017-2031
  • Figure 29: North America Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%) 2017-2031
  • Figure 30: North America Monocyte Activation Test Market Value Share, by Country, 2022 and 2031
  • Figure 31: North America Monocyte Activation Test Market Attractiveness, by Country, 2017-2031
  • Figure 32: North America Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 33: North America Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 34: North America Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 35: Europe Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 36: Europe Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 37: Europe Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 38: Europe Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 39: Europe Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 40: Europe Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 41: Europe Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 42: Asia Pacific Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 43: Asia Pacific Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 44: Asia Pacific Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 45: Asia Pacific Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 46: Asia Pacific Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 47: Asia Pacific Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 48: Asia Pacific Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 49: Latin America Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 50: Latin America Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 51: Latin America Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 52: Latin America Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 53: Latin America Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 54: Latin America Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 54: Latin America Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031
  • Figure 56: Middle East & Africa Monocyte Activation Test Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
  • Figure 57: Middle East & Africa Monocyte Activation Test Market Value Share, by Country/Sub-region, 2022 and 2031
  • Figure 58: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Country/Sub-region, 2017-2031
  • Figure 59: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Product Type, 2017-2031
  • Figure 60: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Source, 2017-2031
  • Figure 61: Middle East & Africa Monocyte Activation Test Market Attractiveness, by Application, 2017-2031
  • Figure 62: Middle East & Africa Monocyte Activation Test Market Attractiveness, by End-user, 2017-2031